dbo:abstract |
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. (en) |
dbo:foundedBy |
dbr:John_T._Treace |
dbo:industry |
dbr:Medical_device |
dbo:keyPerson |
dbr:CEO dbr:James_T._Treace dbr:Joe_W._Ferguson |
dbo:locationCity |
dbr:Ponte_Vedra_Beach dbr:Florida |
dbo:locationCountry |
dbr:United_States_of_America |
dbo:product |
dbr:Foot_and_ankle_surgery |
dbo:thumbnail |
wiki-commons:Special:FilePath/Treace_Medical_Concepts,_Inc.png?width=300 |
dbo:type |
dbr:Public_company |
dbo:wikiPageID |
65487652 (xsd:integer) |
dbo:wikiPageLength |
9374 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1120863492 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Metatarsal_bones dbr:Metatarsophalangeal_joints dbc:Technology_companies_based_in_Florida dbr:United_States_of_America dbr:Public_company dbr:Ponte_Vedra_Beach dbr:Memphis,_Tennessee dbr:Chief_operating_officer dbr:Coronal_plane dbr:Pronation dbr:CEO dbr:CT_scan dbr:Transverse_plane dbr:U.S._Securities_and_Exchange_Commission dbr:US$ dbc:American_companies_established_in_2014 dbr:Florida dbr:Osteotomy dbr:Foot_and_ankle_surgery dbr:Medical_device dbc:Health_care_companies_based_in_Florida dbc:Medical_device_manufacturers dbr:Chairman dbr:Initial_public_offering dbr:Nasdaq dbr:Sesamoid_bone dbr:Ticker_symbol dbr:Fiscal_year dbr:Sagittal_plane dbr:Weight-bearing dbr:James_T._Treace dbr:John_T._Treace dbr:Bunions dbr:Joe_W._Ferguson |
dbp:founder |
dbr:John_T._Treace |
dbp:hqLocationCity |
dbr:Ponte_Vedra_Beach dbr:Florida |
dbp:hqLocationCountry |
dbr:United_States_of_America |
dbp:industry |
Medical devices (en) |
dbp:keyPeople |
dbr:James_T._Treace (en) Joe W. Ferguson (en) John T. Treace (en) |
dbp:logo |
Treace Medical Concepts, Inc.png (en) |
dbp:name |
Treace Medical Concepts, Inc. (en) |
dbp:products |
Foot and ankle surgical devices (en) |
dbp:tradedAs |
NASDAQ:TMCI (en) |
dbp:type |
dbr:Public_company |
dbp:wikiPageUsesTemplate |
dbt:Advert dbt:Increase dbt:Infobox_company dbt:Multiple_issues dbt:Orphan dbt:Reflist dbt:Start_date_and_age dbt:URL dbt:Ubl |
dct:subject |
dbc:Technology_companies_based_in_Florida dbc:American_companies_established_in_2014 dbc:Health_care_companies_based_in_Florida dbc:Medical_device_manufacturers |
rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation |
rdfs:comment |
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. (en) |
rdfs:label |
Treace Medical Concepts (en) |
owl:sameAs |
wikidata:Treace Medical Concepts https://global.dbpedia.org/id/FskuK |
prov:wasDerivedFrom |
wikipedia-en:Treace_Medical_Concepts?oldid=1120863492&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/Treace_Medical_Concepts,_Inc.png |
foaf:isPrimaryTopicOf |
wikipedia-en:Treace_Medical_Concepts |
foaf:name |
Treace Medical Concepts, Inc. (en) |
is dbo:wikiPageRedirects of |
dbr:Treace dbr:Treace_Medical |
is dbo:wikiPageWikiLink of |
dbr:Treace dbr:Treace_Medical |
is foaf:primaryTopic of |
wikipedia-en:Treace_Medical_Concepts |